Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study

Launched by UNIVERSITY HOSPITAL OLOMOUC · Apr 30, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help diagnose extrahepatic cholangiocarcinoma, a type of cancer that affects the bile ducts outside the liver. The researchers are using a technique called Raman spectroscopy, which uses light to create a unique "fingerprint" of the tissue. This could help doctors better understand the type of tissue they are looking at, potentially improving how they diagnose this challenging condition.

To participate in this study, you need to be at least 18 years old and have been diagnosed with extrahepatic cholangiocarcinoma. If you join, you can expect to undergo a procedure called endoscopic retrograde cholangiopancreatography (ERCP), which is often used to look at the bile ducts. The study is currently recruiting participants, so if you or someone you know fits the criteria and is interested, it might be a great opportunity to contribute to important research that could lead to better diagnosis and treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • person older than 18 years, who has known extrahepatic cholangiocarcinoma and is indicated for ERCP
• Exclusion Criteria:
• • disagreement with the study